RxDoctor Payments Data

William Roth, MD

MOHS-Micrographic Surgery · Boynton Beach, FLNPI 1801902846

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 84 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 15.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,044 and has fallen 53.9% since, to $481 in 2025.

$3,468in general payments, 2019–2025

Across 84 payments — averaging $41.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron$526
  • AbbVie$484
  • Sanofi$459
  • Amgen$394
  • Regeneron Healthcare Solutions, Inc.$333
  • Pfizer$239
  • plus $1K from 12 others
$10,000in research payments, 2019–2025

Across 1 payment — averaging $10,000 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sensus Healthcare, Inc.$10K

What the payments were for

  • Food & beverage$3,468100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,468 in reported general payments places this provider in the 70th percentile of 141 mohs-micrographic surgery providers in Florida.

See all mohs-micrographic surgery providers in Florida

Medicare billing

Part B allowed, 2024
$951,794
Medicare patients
1,207
Services billed
13,151

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate77$2,349
Tretinoin12$2,056
Betamethasone Dipropionate37$1,142
Hydrocortisone86$924
Triamcinolone Acetonide106$756
Mometasone Furoate26$729
Metronidazole15$698
Nystatin-TriamcinoloneNystatin/Triamcinolone Acet16$630
Doxycycline Monohydrate56$478
Ketoconazole21$374
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip11$134
SsdSilver Sulfadiazine12$71

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Boynton Beach

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →